Evidence map›Paper›PMID 30348700›Full record

ArticleIn vivo (Athens, Greece)

Application of Platelet-rich Plasma and Tricalcium Phosphate in the Treatment of Comminuted Fractures in Animals.

Tomasz Szponder, Joanna Wessely-Szponder, Aleksandra Sobczyńska-Rak, Beata Żylińska, Radosław P Radzki, Izabella Polkowska

Open access · diamondAbstract read
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Advances with Platelet-Rich Plasma for Bone Healing.Biologics : targets & therapy · 2024
    Review
  6. Release kinetics of growth factors loaded into β-TCP ceramics in anFrontiers in bioengineering and biotechnology · 2024
    Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Tomasz SzponderClinic of Animal Surgery, Faculty of Veterinary Medicine, University of Life Sciences, Lublin, Poland tomszpon@op.pl.
Joanna Wessely-SzponderDepartment of Pathophysiology, Faculty of Veterinary Medicine, University of Life Sciences, Lublin, Poland.
Aleksandra Sobczyńska-RakClinic of Animal Surgery, Faculty of Veterinary Medicine, University of Life Sciences, Lublin, Poland.
Beata ŻylińskaClinic of Animal Surgery, Faculty of Veterinary Medicine, University of Life Sciences, Lublin, Poland.
Radosław P RadzkiDepartment of Animal Physiology, Faculty of Veterinary Medicine, University of Life Sciences, Lublin, Poland.
Izabella PolkowskaClinic of Animal Surgery, Faculty of Veterinary Medicine, University of Life Sciences, Lublin, Poland.
University of Life Sciences in Lublin · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo assess the applicability of β-tri-calcium phosphate (TCP) and platelet-rich plasma (PRP) in the treatment of comminuted fractures in small animals. MATERIAL AND

methodsThe experimental study was carried out on 16 New Zealand White rabbits. After creating the bone defect and performing tibial osteotomy, TCP implants containing activated PRP were introduced into the fracture and the defect. The fracture was stabilised using external fixators or intramedullary nails. After 12 weeks, the animals were euthanised, and radiological, histological, scanning electron microscopy and peripheral quantitative computed tomography examinations were performed. The analysis also covered the results of fracture treatment in 37 small animals (cats and dogs) in which treatment with TCP containing PRP was used as an alternative to cancellous bone implantation.

resultsCorrect bone union was observed in the experimental groups, TCP remained visible at the site of the fracture after 12 weeks. In the clinical application in small animals, bone union was observed in over 91% of treated animals.

conclusionβ-TCP and activated PRP may be an effective method of bone union enhancement in the treatment of comminuted fractures in small animals.

Indexed as

Bone RegenerationPlatelet-Rich PlasmaWound HealingAnimalsBone SubstitutesCalcium PhosphatesCatsDisease Models, AnimalDogsFractures, ComminutedImmunohistochemistryRabbitsX-Ray MicrotomographyBone SubstitutesCalcium Phosphatestricalcium phosphatebone healingcomminuted fracturePlatelet-rich plasmaβ-tricalcium phosphate

Identifiers

PMID30348700
PMCPMC6365725
OpenAlexW2896007958

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.